Verifying a Multi-Compound Peptide Blend
A blend vial contains two or three compounds in a stated ratio. Confirming that ratio is a harder documentation problem than a single-compound vial, and most blend certificates are not written to make it easy.
A single-compound vial poses one documentation question: is this the compound it claims to be, at the purity it claims? A blend vial poses three. Is each compound present? Is each one pure? And are they present in the stated ratio? The third question is the one most certificates answer badly, and it is the one that determines whether a blend is what you paid for.
Why the ratio is the hard part
Consider a vial labelled 10/10 mg — two compounds, equal mass. A certificate stating '≥99% purity' for that vial is close to meaningless on its own. Purity of what? A blend that is 15 mg of one compound and 5 mg of the other can still be 99% pure by mass, in the sense that 99% of the material is peptide rather than contaminant, while being nothing like the product on the label.
The specification you actually need is compositional: how much of each named compound is present. That is a different measurement from purity, and it requires the analysis to resolve and quantify each component separately rather than reporting a single aggregate figure.
What a usable blend certificate shows
| WHAT TO LOOK FOR | WHY IT MATTERS |
|---|---|
| Each compound named individually | An aggregate 'peptide blend' line tells you nothing about composition. |
| A quantity or percentage per compound | This is the ratio claim. Without it, the label ratio is unverified. |
| Identity confirmation per compound | Mass spectrometry should confirm each expected molecular weight, not just one. |
| Purity reported per compound | One compound can be clean while another carries the impurities. |
| A lot number matching the vial | A certificate for a different lot is not evidence about your vial. |
If a blend certificate reports a single purity number and no per-compound breakdown, it is not documenting the product you were sold. That is worth knowing before the diluent goes in, because reconstitution destroys your ability to send the material back.
Reading the chromatogram
In an HPLC trace of a well-made blend, each component appears as its own peak at its own retention time. The relative peak areas correspond to the relative amounts present. Two compounds intended at equal mass should produce peaks of broadly comparable area — allowing for the fact that different peptides absorb differently at the detection wavelength, so areas are not a direct one-to-one readout of mass.
What you are checking for is gross disagreement with the label. A vial sold as 10/10 whose trace shows one component at a small fraction of the other is telling you something the summary line did not.
Mass spectrometry is the identity half of the same question. Each expected compound has a known molecular weight; the spectrum should show each one. A blend certificate reporting a single mass confirmation for a three-compound product has confirmed one third of the label.
Why blends exist at all
The practical reason is handling. Three compounds in one vial means one reconstitution, one storage container, and one set of concentration arithmetic instead of three. For work involving a fixed combination at a fixed ratio, that is a genuine reduction in handling error — every additional vial is another opportunity to mislabel, miscalculate, or contaminate.
The trade-off is inflexibility and verification burden. A blend fixes the ratio at the point of manufacture: you cannot adjust one component independently. And, as above, confirming you received the stated ratio requires better documentation than a single-compound vial does.
Concentration math with a blend
The arithmetic is the same division as any reconstitution, applied per component. Add 2 mL of bacteriostatic water to a 10/10 mg vial and you have a solution at 5 mg/mL of each compound — total peptide 10 mg/mL. The total mass matters for the vial's capacity; the per-component figure is what describes the solution.
| BLEND | DILUENT | PER-COMPONENT CONCENTRATION |
|---|---|---|
| BPC-157 / TB-500 — 10/10 mg | 2 mL | 5 mg/mL each |
| CJC-1295 / Ipamorelin — 5/5 mg | 2 mL | 2.5 mg/mL each |
| Tesamorelin / Ipamorelin — 10/10 mg | 5 mL | 2 mg/mL each |
| Tesa / Ipa / CJC — 6/3/3 mg | 3 mL | 2 / 1 / 1 mg/mL |
Note the last row: an uneven blend produces uneven concentrations, and the label ratio carries through to the solution unchanged. Reconstitution never rebalances a blend — whatever ratio was in the powder is the ratio in the vial.
Handling differences worth knowing
Blends inherit the strictest requirement among their components. If one compound in a three-part blend needs colder storage or is more light-sensitive than the others, the vial as a whole is bound by that constraint — you cannot store the tolerant components separately once they share a vial.
Colour is also worth anticipating. Any blend containing GHK-Cu will reconstitute blue, because the copper complex is coloured. In a blend that is expected, not a defect — but it does mean colour is no longer a useful indicator of a problem in that particular vial.
The short version
A blend is a formulation claim, and a formulation claim needs compositional evidence. Ask for a certificate that names each compound, quantifies each one, confirms each identity by mass, and carries the lot number printed on your vial. Anything less documents a product, but not necessarily the one in your hand.
Every TrueBond blend publishes its lot certificate before the lot goes on sale, and the QR code on the vial resolves to that lot's own document.
Research use only. Products referenced are supplied for in-vitro and qualified laboratory research. They are not approved by the FDA and are not intended for human or animal consumption, nor to diagnose, treat, cure, or prevent any disease.